The global dermatology Contract Research Organisation (CRO) market is on the rise. It is expected to expand from $5.42 billion in 2024 to more than $9 billion by 2033. But for savvy industry leaders, the true opportunity is not just in the worldwide numbers. It is in the fast-changing possibilities in key countries like India.
Two main factors are making the subcontinent a focus for new research: the rising number of skin conditions and the increase in new drug development. So, what is fueling this growth, and how can your clinic capitalise on it?
The engine of growth
Several key factors are driving the growing need for specialised dermatology CRO services:
- Rising disease burden: Chronic conditions like psoriasis, eczema, and skin cancers are becoming increasingly common. It is creating an urgent need for new and effective treatments.
- Biopharma’s focus: There’s a significant expansion in the development of innovative topical and systemic therapies. Running trials for skin treatments is complex, so specialist partners are needed.
- The Outsourcing Shift: Pharmaceutical companies are increasingly leveraging CROs to streamline R&D, control costs, and tap into specialised expertise and regional infrastructure.
The game changers
The traditional clinical trial model is changing. In skin disease research, using new technology is key to working faster and keeping patients involved.
- Embrace decentralised clinical trials (DCTs): Patients can now join dermatology trials from home using video calls and remote tools. This is a huge advantage in India, making it easier to find and keep patients in studies.
- Leverage the power of AI: Artificial Intelligence is changing how we measure results in trials. AI tools analyze skin images with great accuracy, replacing older, less consistent human methods.
- Personalised medicine is here: The future of dermatology is personalised care. CROs that can use real-world data and biomarkers to customise treatments are the ones who will lead the next wave of innovation.
Seizing the opportunity
While the market is growing globally, India stands out with a uniquely favorable environment:
- A large population of patients is ready for trials.
- Increasing government support for research.
- A skilled network of doctors and investigators.
For dermatology CROs, the advantage is about speed, scale, and quality data, not just cost.
Hence, the message is clear: the dermatology CRO landscape is evolving rapidly. Success will come to clinics that grow their business in key regions like India. At the same time, they must also start using the digital tools that are shaping the future of research. The time to act is now.